Galanthamine, an Amaryllidaceae type alkaloid, is an AChE inhibitor marketed as a hydrobromide salt for the treatment of Alzheimer's disease, poliomyelitis and other neurological diseases. Although the chemical synthesis of galanthamine has been successfully performed, plants are the main source of its production. The phytochemical and biotechnological aspects of plants currently used for galanthamine production, namely Leucojum aestivum, Narcissus ssp. Ungernia victoris and Lycoris radiata, are summarized in the present paper.
No takes yet. Share an insight, caveat, or question.
Berkov et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: